MIXiii-Biomed 2018 Registration is now open
MIXiii-Biomed 2018 Conference - Innovation and Trends shaping the future of Healthcare Systems and Life Sciences It is with great pleasure and pride that we invite our old and…
Researchers Develop Vaccine To Protect Against Influenza
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a…
First aging innovation lab opens in Israel
Israel’s first Innovation Lab for Healthy Aging has been launched in Beersheva, simulating the challenges in the everyday living environment of senior citizens in order to inspire solutions. The new…
Physicists take first step toward cell-sized robots
An electricity-conducting, environment-sensing, shape-changing machine the size of a human cell? Is that even possible? Cornell physicists Paul McEuen and Itai Cohen not only say yes, but they’ve actually built the “muscle” for…
MIXiii-Biomed 2018 Early Bird Registration
Be a trend-setter and stay in the forefront of developments in the field of Biomed. Register to the MIXiii-Biomed 2018 Conference and Exhibition before May 1, 2018 and save…
Israeli smart software harnesses flood of data to manage diabetes care
DreaMed Diabetes's cloud-based Advisor Pro helps doctors craft or modify insulin plans based on 288 daily glucose level readings By URVASHI VERMA 21 | February 2018, 12:52 pm Petah Tikva-based DreaMed Diabetes has developed…
Medical data co MDClone raises $10m
MDClone has also signed a strategic partnership agreement with the Institute of Informatics at the Washington University School of Medicine. MDClone has raised $10 million from the OrbiMed Advisors LLC and Lightspeed Ventures funds,…
13 of the biggest health breakthroughs in Israel in 2017
A compound that disables cancer cells, an artificial cornea, the world’s first bone implant: 2017 saw major medical advances. We bring you the best. By Nicky Blackburn Compound kills energy generating…
Cellect Announces Breakthrough Clinical Results
First Group of Patients in Clinical Trial With Cellect's ApoGraft Stem Cell Transplant Follow up Results 100% Acceptance and Zero Related Adverse Events Dr. Shai Yarkoni, Cellect CEO commented: "These…